Journal Article Ahead of print
PubMed: 42768983 DOI: 10.1017/ipm.2026.10212
Mental health and substance use in Europe: initial steps towards a common European approach.
Ir J Psychol Med
Authors: Linda Montanari, Francina Fonseca, Marc Auriacombe, Alexander Baldacchino, Alessandra Bo, Gabriele Fischer, Ines Hasselberg, Andrej Kastelic, Konstantinos Kokkolis, Melpomeni Minerva Malliori, Joan I Mestre-Pintó, Charlotte Migchels, Erikas Simonavičius, Narayanan Subramanian, Liesbeth Vandam, Cinta Mancheno, Tore Willy Lie, Anita White, Marica Ferri, Marta Torrens
Affiliations
- European Union Drugs Agency, Portugal.
- Hospital Parc de Salut Mar, Barcelona, Spain.
- Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
- Red de Investigación en Atención Primaria en Adicciones (RIAPAd), Spain.
- Addiction Team, SANPSY Lab, CNRS UMR 6033, University of Bordeaux, Bordeaux, France.
- Addiction Treatment Services, Charles Perrens Hospital and CHU de Bordeaux, Bordeaux, France.
- Psychiatry and Addiction, University of St Andrews Faculty of Medicine, UK.
- EUDA Scientific Committee, Portugal.
- Medical University of Vienna, Austria.
- SEEAnet, Ljubiana, Slovenia.
- Organisation Against Drugs of Greece, Athens, Greece.
- Psychiatry, National and Kapodistrian University of Athens, Greece.
- Department of Law Universitat Pompeu Fabra, Barcelona, Spain.
- Health and Social Responses, European Union Drugs Agency (EUDA), Portugal.
- Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Belgium.
- Health Service Executive, Ireland.
- University of Huelva, Spain.
- University of Inland Norway, Norway.
Abstract
BACKGROUND AND AIMS
Comorbid substance use and other mental health disorders contribute to more than one million years lived with disability in Europe according to the Global Burden of Disease study. They require a comprehensive approach, yet, in Europe, there is considerable variability in the treatment of these patients. The European Union Drugs Agency (EUDA) is committed to address comorbidity in Europe by providing evidence of epidemiological situation and approaches to interventions and supporting a common European approach.
METHODS
The methods used to support the promotion of a European approach to comorbidity were the following: a) setting up an EUDA Advisory Board on dual disorders, consisting of international experts guiding and overseeing the EUDA efforts in this field, b) the introduction of a voluntary item on dual disorders in the European data collection on people entering drug treatment (Treatment Demand Indicator (TDI) and c) a survey mapping existing care models in Europe was conducted.
MeSH
Comorbidity, Pharmaceutical Preparations, Therapeutics, Mental Health, Psychiatry